E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 2.89 EUR 1.12%
Market Cap: 276.3m EUR
EAPI
/
Income Statement
/
Revenue

Euroapi SAS
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Euroapi SAS
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
E
Euroapi SAS
PAR:EAPI
Revenue
€919.2m
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Sanofi SA
PAR:SAN
Revenue
€44.3B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
-2%
Ipsen SA
PAR:IPN
Revenue
€3.6B
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
10%
Vetoquinol SA
PAR:VETO
Revenue
€537.5m
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
6%
Virbac SA
PAR:VIRP
Revenue
€1.4B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
6%
Medincell SA
PAR:MEDCL
Revenue
€10.7m
CAGR 3-Years
8%
CAGR 5-Years
32%
CAGR 10-Years
N/A

Euroapi SAS
Glance View

Market Cap
275.3m EUR
Industry
Pharmaceuticals

EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

EAPI Intrinsic Value
7.91 EUR
Undervaluation 63%
Intrinsic Value
Price
E
What is Intrinsic Value?

See Also

What is Euroapi SAS's Revenue?
Revenue
919.2m EUR

Based on the financial report for Dec 31, 2024, Euroapi SAS's Revenue amounts to 919.2m EUR.

What is Euroapi SAS's Revenue growth rate?
Revenue CAGR 5Y
0%

Over the last year, the Revenue growth was -10%. The average annual Revenue growth rates for Euroapi SAS have been 1% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.